IRVINE, CA, and HERSTAL, BELGIUM - November 14, 2016 - MDxHealth SA (Euronext: MDXH.BR), today announced that Dr. Jan Groen, Chief Executive Officer, will present at the following investor conferences this month:
• 2016 Canaccord Genuity Medical Technology & Diagnostics Forum
o Date: Thursday, November 17, 2016, 4:00 PM Eastern Time
o Location: Westin Grand Central, 212 East 42nd Street, New York
• 28th Annual Piper Jaffray Healthcare Conference
o Date: Tuesday, November 29, 2016, 2:10 PM Eastern Time
o Location: The Lotte New York Palace, 455 Madison Avenue, New York
About MDxHealth®
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy.. For more information, visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth.
